|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,329.00 INR | -0.56% |
|
-1.24% | -0.99% |
| 12/02 | Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy | MT |
| 11/02 | Divi's Laboratories Limited, Q3 2026 Earnings Call, Feb 11, 2026 |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 16.93 | 18.49 | 9.1 | 7.65 | 9.91 | |||||
Return on Total Capital | 19.63 | 21.23 | 10.34 | 8.69 | 11.25 | |||||
Return On Equity % | 23.9 | 28.16 | 14.89 | 12.15 | 15.35 | |||||
Return on Common Equity | 23.9 | 28.16 | 14.89 | 12.15 | 15.35 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 64.46 | 64.66 | 57.81 | 57.27 | 60.2 | |||||
SG&A Margin | 12 | 10.68 | 12.71 | 14.1 | 13.44 | |||||
EBITDA Margin % | 41.13 | 43.3 | 30.44 | 28.11 | 31.71 | |||||
EBITA Margin % | 37.52 | 39.87 | 26.08 | 23.34 | 27.46 | |||||
EBIT Margin % | 37.52 | 39.87 | 26.08 | 23.34 | 27.46 | |||||
Income From Continuing Operations Margin % | 28.47 | 33.04 | 23.47 | 20.4 | 23.41 | |||||
Net Income Margin % | 28.47 | 33.04 | 23.47 | 20.4 | 23.41 | |||||
Net Avail. For Common Margin % | 28.47 | 33.04 | 23.47 | 20.4 | 23.41 | |||||
Normalized Net Income Margin | 23.94 | 25.71 | 19.07 | 17.22 | 19.46 | |||||
Levered Free Cash Flow Margin | 10.95 | 4.45 | 18.96 | -1.32 | 1.76 | |||||
Unlevered Free Cash Flow Margin | 10.95 | 4.45 | 18.96 | -1.3 | 1.78 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.72 | 0.74 | 0.56 | 0.52 | 0.58 | |||||
Fixed Assets Turnover | 1.72 | 1.95 | 1.6 | 1.5 | 1.56 | |||||
Receivables Turnover (Average Receivables) | 4.51 | 4.37 | 3.68 | 3.97 | 3.83 | |||||
Inventory Turnover (Average Inventory) | 1.24 | 1.27 | 1.12 | 1.08 | 1.16 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.55 | 6.99 | 8.46 | 7.57 | 6.94 | |||||
Quick Ratio | 3.47 | 4.41 | 5.51 | 4.74 | 4.48 | |||||
Operating Cash Flow to Current Liabilities | 1.75 | 1.6 | 2.23 | 0.99 | 1.14 | |||||
Days Sales Outstanding (Average Receivables) | 80.91 | 83.52 | 99.07 | 92.12 | 95.29 | |||||
Days Outstanding Inventory (Average Inventory) | 295.37 | 286.7 | 324.61 | 337.61 | 314.54 | |||||
Average Days Payable Outstanding | 89.58 | 73.9 | 82.45 | 82.08 | 83.78 | |||||
Cash Conversion Cycle (Average Days) | 286.7 | 296.31 | 341.22 | 347.65 | 326.04 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.05 | 0.03 | 0.03 | 0.02 | 0.03 | |||||
Total Debt / Total Capital | 0.05 | 0.03 | 0.03 | 0.02 | 0.03 | |||||
LT Debt/Equity | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | |||||
Long-Term Debt / Total Capital | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | |||||
Total Liabilities / Total Assets | 13.73 | 12.31 | 11.58 | 12.28 | 11.59 | |||||
EBIT / Interest Expense | 6.7T | 9.66T | 6.14T | 610.33 | 1.28T | |||||
EBITDA / Interest Expense | 7.35T | 10.49T | 7.17T | 735.33 | 1.48T | |||||
(EBITDA - Capex) / Interest Expense | 5.02T | 8.56T | 5.73T | 401 | 765.5 | |||||
Total Debt / EBITDA | 0 | 0 | 0 | 0 | 0 | |||||
Net Debt / EBITDA | -0.73 | -0.71 | -1.75 | -1.67 | -1.19 | |||||
Total Debt / (EBITDA - Capex) | 0 | 0 | 0 | 0 | 0 | |||||
Net Debt / (EBITDA - Capex) | -1.06 | -0.86 | -2.18 | -3.07 | -2.3 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 29.2 | 28.56 | -13.31 | 1 | 19.31 | |||||
Gross Profit, 1 Yr. Growth % | 42.86 | 28.97 | -22.5 | 0 | 25.42 | |||||
EBITDA, 1 Yr. Growth % | 57.3 | 35.36 | -39.07 | -6.73 | 34.6 | |||||
EBITA, 1 Yr. Growth % | 59.51 | 36.63 | -43.29 | -9.62 | 40.36 | |||||
EBIT, 1 Yr. Growth % | 59.51 | 36.63 | -43.29 | -9.62 | 40.36 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 44.15 | 49.19 | -38.41 | -12.28 | 36.94 | |||||
Net Income, 1 Yr. Growth % | 44.15 | 49.19 | -38.41 | -12.28 | 36.94 | |||||
Normalized Net Income, 1 Yr. Growth % | 51.38 | 38.07 | -35.7 | -8.58 | 34.83 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 44.16 | 49.19 | -38.41 | -12.26 | 36.93 | |||||
Accounts Receivable, 1 Yr. Growth % | 18.62 | 44.58 | -26.05 | 20.25 | 26.67 | |||||
Inventory, 1 Yr. Growth % | 15.1 | 31.86 | 6.07 | 6.13 | 1.63 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 19.24 | 8.57 | 2.96 | 11.85 | 17.18 | |||||
Total Assets, 1 Yr. Growth % | 26.22 | 24.14 | 7.96 | 7.14 | 9.45 | |||||
Tangible Book Value, 1 Yr. Growth % | 27.15 | 26.17 | 8.88 | 6.31 | 10.3 | |||||
Common Equity, 1 Yr. Growth % | 27.15 | 26.18 | 8.86 | 6.3 | 10.3 | |||||
Cash From Operations, 1 Yr. Growth % | 60.12 | -1.8 | 28.66 | -48.72 | 31.09 | |||||
Capital Expenditures, 1 Yr. Growth % | -23.07 | -21.64 | -33.68 | 112.05 | 43.37 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -417.55 | -47.49 | 269.59 | -107.03 | -259.42 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -422.29 | -47.47 | 269.43 | -106.9 | -263.59 | |||||
Dividend Per Share, 1 Yr. Growth % | 25 | 50 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 18.7 | 28.88 | 5.57 | -6.43 | 9.78 | |||||
Gross Profit, 2 Yr. CAGR % | 21.92 | 35.74 | -0.02 | -11.94 | 11.99 | |||||
EBITDA, 2 Yr. CAGR % | 23.65 | 45.91 | -9.18 | -24.62 | 12.05 | |||||
EBITA, 2 Yr. CAGR % | 23.71 | 47.63 | -11.98 | -28.41 | 12.63 | |||||
EBIT, 2 Yr. CAGR % | 23.71 | 47.63 | -11.98 | -28.41 | 12.63 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 21.11 | 46.65 | -4.14 | -26.48 | 9.6 | |||||
Net Income, 2 Yr. CAGR % | 21.11 | 46.65 | -4.14 | -26.48 | 9.6 | |||||
Normalized Net Income, 2 Yr. CAGR % | 20.8 | 44.57 | -5.78 | -23.41 | 11.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 21.11 | 46.66 | -4.14 | -26.48 | 9.61 | |||||
Accounts Receivable, 2 Yr. CAGR % | 20.05 | 30.96 | 3.4 | -5.69 | 23.42 | |||||
Inventory, 2 Yr. CAGR % | 10.02 | 23.19 | 18.26 | 6.1 | 3.86 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 30.84 | 13.78 | 5.73 | 7.31 | 14.48 | |||||
Total Assets, 2 Yr. CAGR % | 15.77 | 25.18 | 15.76 | 7.55 | 8.29 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.59 | 26.66 | 17.21 | 7.59 | 8.29 | |||||
Common Equity, 2 Yr. CAGR % | 15.58 | 26.67 | 17.2 | 7.57 | 8.28 | |||||
Cash From Operations, 2 Yr. CAGR % | 42.83 | 25.39 | 12.4 | -18.78 | -18.01 | |||||
Capital Expenditures, 2 Yr. CAGR % | 11.43 | -22.36 | -27.91 | 18.59 | 74.36 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 365.4 | 28.78 | 39.31 | -49.03 | -66.52 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 356.96 | 29.76 | 39.3 | -49.51 | -66.4 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 36.93 | 22.47 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 21.44 | 21.9 | 12.92 | 4.02 | 1.47 | |||||
Gross Profit, 3 Yr. CAGR % | 25.56 | 24.23 | 12.61 | 0 | -0.92 | |||||
EBITDA, 3 Yr. CAGR % | 31.25 | 27.44 | 9.06 | -8.37 | -8.54 | |||||
EBITA, 3 Yr. CAGR % | 32.35 | 27.87 | 7.31 | -11.2 | -10.4 | |||||
EBIT, 3 Yr. CAGR % | 32.35 | 27.87 | 7.31 | -11.2 | -10.4 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 31.28 | 29.83 | 9.82 | -6.92 | -9.55 | |||||
Net Income, 3 Yr. CAGR % | 31.28 | 29.83 | 9.82 | -6.92 | -9.55 | |||||
Normalized Net Income, 3 Yr. CAGR % | 29.3 | 26.3 | 10.35 | -6.79 | -7.52 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 31.28 | 29.83 | 9.83 | -6.92 | -9.55 | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.23 | 27.72 | 8.24 | 8.75 | 4.06 | |||||
Inventory, 3 Yr. CAGR % | 16.67 | 16.86 | 17.2 | 14.07 | 4.59 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 27.86 | 22.95 | 10.05 | 7.73 | 10.5 | |||||
Total Assets, 3 Yr. CAGR % | 16.66 | 18.5 | 19.15 | 12.82 | 8.18 | |||||
Tangible Book Value, 3 Yr. CAGR % | 16.22 | 19.01 | 20.43 | 13.46 | 8.49 | |||||
Common Equity, 3 Yr. CAGR % | 16.19 | 19.01 | 20.43 | 13.45 | 8.47 | |||||
Cash From Operations, 3 Yr. CAGR % | 35.89 | 26.06 | 26.47 | -13.48 | -4.73 | |||||
Capital Expenditures, 3 Yr. CAGR % | 49.23 | -0.91 | -26.33 | 3.29 | 26.33 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 39.99 | 124.48 | 83.01 | -48.52 | -25.46 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 39.95 | 121.78 | 83.91 | -48.84 | -25.29 | |||||
Dividend Per Share, 3 Yr. CAGR % | 25.99 | 23.31 | 23.31 | 14.47 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.04 | 17.13 | 14.82 | 9.66 | 11.65 | |||||
Gross Profit, 5 Yr. CAGR % | 15.29 | 18.75 | 14.62 | 8.25 | 12.37 | |||||
EBITDA, 5 Yr. CAGR % | 15.05 | 21.14 | 13.27 | 3.3 | 10.25 | |||||
EBITA, 5 Yr. CAGR % | 14.9 | 21.2 | 12.43 | 1.39 | 9.41 | |||||
EBIT, 5 Yr. CAGR % | 14.9 | 21.2 | 12.43 | 1.39 | 9.41 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12 | 22.79 | 15.76 | 3.41 | 9.74 | |||||
Net Income, 5 Yr. CAGR % | 12 | 22.79 | 15.76 | 3.41 | 9.74 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.83 | 21.47 | 13.92 | 3.4 | 10.58 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12 | 22.79 | 15.76 | 3.41 | 9.74 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.74 | 21.89 | 12.06 | 13.13 | 14.08 | |||||
Inventory, 5 Yr. CAGR % | 12.17 | 16.47 | 17.31 | 12.43 | 11.67 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 21 | 19.08 | 18.5 | 16.44 | 11.8 | |||||
Total Assets, 5 Yr. CAGR % | 17.06 | 16.78 | 16.3 | 13.99 | 14.68 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.71 | 16.96 | 16.61 | 14.3 | 15.42 | |||||
Common Equity, 5 Yr. CAGR % | 16.7 | 16.96 | 16.6 | 14.3 | 15.41 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.41 | 10.69 | 25.96 | 5.73 | 6.33 | |||||
Capital Expenditures, 5 Yr. CAGR % | 18.13 | 13.62 | 11.55 | 6.47 | 3.98 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 88.14 | -7.65 | 39.57 | 24.06 | -7.24 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 86.44 | -7.66 | 39.54 | 22.7 | -6.83 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.87 | 24.57 | 24.57 | 13.4 | 13.4 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















